Targeting the telosome: Therapeutic implications
- 5 February 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1792 (4) , 309-316
- https://doi.org/10.1016/j.bbadis.2009.01.014
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Telomere dysfunction and tumour suppression: the senescence connectionNature Reviews Cancer, 2008
- The telosome/shelterin complex and its functionsGenome Biology, 2008
- Photochemically enhanced delivery of a cell‐penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cellsCell Proliferation, 2007
- 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cellsNucleic Acids Research, 2007
- Telomere Maintenance through Spatial Control of Telomeric ProteinsMolecular and Cellular Biology, 2007
- Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairmentBiochemical Pharmacology, 2007
- Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanismBritish Journal of Cancer, 2007
- A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assemblyProceedings of the National Academy of Sciences, 2006
- Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cellsEuropean Journal Of Cancer, 2005
- The Hallmarks of CancerCell, 2000